North Star Investment Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $349K | Hold |
4,675
| – | – | 0.02% | 348 |
|
|
2025
Q1 | $297K | Hold |
4,675
| – | – | 0.02% | 368 |
|
|
2024
Q4 | $365K | Hold |
4,675
| – | – | 0.03% | 349 |
|
|
2024
Q3 | $376K | Hold |
4,675
| – | – | 0.03% | 353 |
|
|
2024
Q2 | $387K | Hold |
4,675
| – | – | 0.03% | 349 |
|
|
2024
Q1 | $399K | Hold |
4,675
| – | – | 0.03% | 353 |
|
|
2023
Q4 | $400K | Hold |
4,675
| – | – | 0.03% | 352 |
|
|
2023
Q3 | $419K | Sell |
4,675
-4,715
| -50% | -$422K | 0.04% | 345 |
|
|
2023
Q2 | $799K | Hold |
9,390
| – | – | 0.06% | 266 |
|
|
2023
Q1 | $777K | Hold |
9,390
| – | – | 0.06% | 275 |
|
|
2022
Q4 | $739K | Buy |
+9,390
| New | +$739K | 0.07% | 282 |
|